193 related articles for article (PubMed ID: 31095645)
41. The Kaposi's sarcoma-associated herpesvirus (KSHV) non-structural membrane protein K15 is required for viral lytic replication and may represent a therapeutic target.
Abere B; Mamo TM; Hartmann S; Samarina N; Hage E; Rückert J; Hotop SK; Büsche G; Schulz TF
PLoS Pathog; 2017 Sep; 13(9):e1006639. PubMed ID: 28938025
[TBL] [Abstract][Full Text] [Related]
42. Virus-Like Vesicles of Kaposi's Sarcoma-Associated Herpesvirus Activate Lytic Replication by Triggering Differentiation Signaling.
Gong D; Dai X; Xiao Y; Du Y; Chapa TJ; Johnson JR; Li X; Krogan NJ; Deng H; Wu TT; Sun R
J Virol; 2017 Aug; 91(15):. PubMed ID: 28515293
[TBL] [Abstract][Full Text] [Related]
43. S-Like-Phase Cyclin-Dependent Kinases Stabilize the Epstein-Barr Virus BDLF4 Protein To Temporally Control Late Gene Transcription.
Sato Y; Watanabe T; Suzuki C; Abe Y; Masud HMAA; Inagaki T; Yoshida M; Suzuki T; Goshima F; Adachi J; Tomonaga T; Murata T; Kimura H
J Virol; 2019 Apr; 93(8):. PubMed ID: 30700607
[TBL] [Abstract][Full Text] [Related]
44. Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: cis-acting requirements for replication and ori-Lyt-associated RNA transcription.
Wang Y; Li H; Chan MY; Zhu FX; Lukac DM; Yuan Y
J Virol; 2004 Aug; 78(16):8615-29. PubMed ID: 15280471
[TBL] [Abstract][Full Text] [Related]
45. Genome-Wide Mapping of the Binding Sites and Structural Analysis of Kaposi's Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor 2 Reveal that It Is a DNA-Binding Transcription Factor.
Hu H; Dong J; Liang D; Gao Z; Bai L; Sun R; Hu H; Zhang H; Dong Y; Lan K
J Virol; 2016 Feb; 90(3):1158-68. PubMed ID: 26537687
[TBL] [Abstract][Full Text] [Related]
46. Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway.
Wang SE; Wu FY; Chen H; Shamay M; Zheng Q; Hayward GS
J Virol; 2004 Apr; 78(8):4248-67. PubMed ID: 15047839
[TBL] [Abstract][Full Text] [Related]
47. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression.
Krishnan HH; Naranatt PP; Smith MS; Zeng L; Bloomer C; Chandran B
J Virol; 2004 Apr; 78(7):3601-20. PubMed ID: 15016882
[TBL] [Abstract][Full Text] [Related]
48. Kaposi's sarcoma-associated herpesvirus vIRF2 protein utilizes an IFN-dependent pathway to regulate viral early gene expression.
Koch S; Damas M; Freise A; Hage E; Dhingra A; Rückert J; Gallo A; Kremmer E; Tegge W; Brönstrup M; Brune W; Schulz TF
PLoS Pathog; 2019 May; 15(5):e1007743. PubMed ID: 31059555
[TBL] [Abstract][Full Text] [Related]
49. Acetylation changes at lysine 5 of histone H4 associated with lytic gene promoters during reactivation of Kaposi's sarcoma-associated herpesvirus.
Hwang LR; Cha S; Jong JE; Jang JH; Seo T
Acta Virol; 2014; 58(3):282-6. PubMed ID: 25283865
[TBL] [Abstract][Full Text] [Related]
50. Better late than never: A unique strategy for late gene transcription in the beta- and gammaherpesviruses.
Dremel SE; Didychuk AL
Semin Cell Dev Biol; 2023 Sep; 146():57-69. PubMed ID: 36535877
[TBL] [Abstract][Full Text] [Related]
51. Kaposi's Sarcoma-Associated Herpesvirus Nonstructural Membrane Protein pK15 Recruits the Class II Phosphatidylinositol 3-Kinase PI3K-C2α To Activate Productive Viral Replication.
Abere B; Samarina N; Gramolelli S; Rückert J; Gerold G; Pich A; Schulz TF
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950425
[TBL] [Abstract][Full Text] [Related]
52. Characterization of Kaposi's sarcoma-associated herpesvirus (KSHV) K1 promoter activation by Rta.
Bowser BS; Morris S; Song MJ; Sun R; Damania B
Virology; 2006 May; 348(2):309-27. PubMed ID: 16546233
[TBL] [Abstract][Full Text] [Related]
53. Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency.
Lan K; Murakami M; Choudhuri T; Kuppers DA; Robertson ES
Virology; 2006 Aug; 351(2):393-403. PubMed ID: 16701788
[TBL] [Abstract][Full Text] [Related]
54. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection.
Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B
J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824
[TBL] [Abstract][Full Text] [Related]
55. An Sp1 response element in the Kaposi's sarcoma-associated herpesvirus open reading frame 50 promoter mediates lytic cycle induction by butyrate.
Ye J; Shedd D; Miller G
J Virol; 2005 Feb; 79(3):1397-408. PubMed ID: 15650166
[TBL] [Abstract][Full Text] [Related]
56. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.
Purushothaman P; Thakker S; Verma SC
J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714
[TBL] [Abstract][Full Text] [Related]
57. Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.
Sanchez EL; Pulliam TH; Dimaio TA; Thalhofer AB; Delgado T; Lagunoff M
J Virol; 2017 May; 91(10):. PubMed ID: 28275189
[TBL] [Abstract][Full Text] [Related]
58. Transcriptional regulation of the Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor gene.
Chen J; Ueda K; Sakakibara S; Okuno T; Yamanishi K
J Virol; 2000 Sep; 74(18):8623-34. PubMed ID: 10954564
[TBL] [Abstract][Full Text] [Related]
59. Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency.
Lu F; Zhou J; Wiedmer A; Madden K; Yuan Y; Lieberman PM
J Virol; 2003 Nov; 77(21):11425-35. PubMed ID: 14557628
[TBL] [Abstract][Full Text] [Related]
60. Interaction between ORF24 and ORF34 in the Kaposi's Sarcoma-Associated Herpesvirus Late Gene Transcription Factor Complex Is Essential for Viral Late Gene Expression.
Davis ZH; Hesser CR; Park J; Glaunsinger BA
J Virol; 2016 Jan; 90(1):599-604. PubMed ID: 26468530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
